Nanotechnologies and regenerative medical approaches for space and terrestrial medicine

Aviation Space and Environmental Medicine

Volumn 83, Issue 11, 2012, Pages 1025-1036

  Grattoni, Alessandro ^a   Tasciotti, Ennio ^a   Fine, Daniel ^a   Fernandez Moure, Joseph S ^a   Sakamoto, Jason ^a   Hu, Ye ^a   Weiner, Bradley ^a   Ferrari, Mauro ^a   Parazynski, Scott ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Nanochannels; Nanomedicine; Proteomics; Regenerative medicine; Scaffolds; Silicon nanotechnology; Space medicine

Indexed keywords

NANOMATERIAL; PROTEIN; TISSUE SCAFFOLD;

AEROSPACE MEDICINE; ARTIFICIAL MEMBRANE; CHEMISTRY; DRUG DELIVERY SYSTEM; HEART; HUMAN; MASS SPECTROMETRY; NANOTECHNOLOGY; PROTEOMICS; REGENERATIVE MEDICINE; REVIEW;

AEROSPACE MEDICINE; DRUG DELIVERY SYSTEMS; HEART; HUMANS; MASS SPECTROMETRY; MEMBRANES, ARTIFICIAL; NANOSTRUCTURES; NANOTECHNOLOGY; PROTEINS; PROTEOMICS; REGENERATIVE MEDICINE; TISSUE SCAFFOLDS;

EID: 84871113288     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.3307.2012     Document Type: Review

References (98)

1. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
2. Alge DL, Bennett J, Treasure T, Voytik-Harbin S, Goebel WS, Chu TM. Poly(propylene fumarate) reinforced dicalcium phosphate dihydrate cement composites for bone tissue engineering. J Biomed Mater Res A 2012, 100, 1792-802.
3. Ananta JS, Godin B, Sethi R, Moriggi L, Liu X, et al. Geometrical confi nement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol 2010, 5, 815-21.
4. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1, 845-67.
5. Ashjari M, Khoee S, Mahdavian AR, Rahmatolahzadeh R. Selfassembled nanomicelles using PLGA-PEG amphiphilic block copolymer for insulin delivery: a physicochemical investigation and determination of CMC values. J Mater Sci Mater Med 2012, 23, 943-53.
6. Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 2011, 10, 389-97.
7. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome Med 2009, 1, 2.
8. Bansal SS, Vadhanam MV, Gupta RC. Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin. Pharm Res 2011, 28, 1121-30.
9. Bayer Pharmaceuticals Corporation and ALZA Corporation. Viadur w (leuprolide acetate implant). Viadur Prescribing Information. Leverkusen, Germany: Bayer Corporation; 2005, 08840302.
10. Bhavaraju S, Gordon J, Joshi A. A compact, controllable, implantable delivery device driven by electro-osmosis. Drug Deliviery Technology 2010, 10, 24-31.
11. Bouamrani A, Hu Y, Tasciotti E, Li L, Chiappini C, et al. Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome. Proteomics 2010, 10, 496-505.
12. Bruzewicz DA, Reches M, Whitesides GM. Low-cost printing of poly(dimethylsiloxane) barriers to defi ne microchannels in paper. Anal Chem 2008, 80, 3387-92.
13. Buijze GA, Richardson S, Jupiter JB. Successful reconstruction for complex malunions and nonunions of the tibia and femur. J Bone Joint Surg Am 2011, 93, 485-92.
14. National Cancer Institute. Statistics. Retrieved January 2012 from http://www.cancer.gov/statistics.
15. Canham LT, Reeves CL, King DO, Branfield PJ, Crabb JG, Ward MCL. Bioactive polycrystalline silicon. Advanced Materials 1996, 8, 580-2.
16. Canham LT, Reeves CL, Newey JP, Houlton MR, Cox TI, et al. Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma. Advanced Materials 1999, 11, 1505-7.
17. Cejka J, ed. Incorporation of ordered mesoporous silica inside a bioactive porous scaffold in view of controlled drug release. Proceedings of the 3rd International Zeolite Symposium (3rd FEZA); August 23-26, 2005, Prague. Amsterdam: Elsevier Science; 2005.
18. Chambers G, Cash P, Murray G. Proteomics: a new approach to the study of disease. J Pathol 2000, 192, 280-8.
19. Chen L, Choo J, Yan B. The microfabricated electrokinetic pump: a potential promising drug delivery technique. Expert Opin Drug Deliv 2007, 4, 119-29.
20. Cheng CM, Martinez AW, Gong J, Mace CR, Phillips ST, Carrilho E, et al. Paper-Based ELISA. Angewandte Chemie International Edition 2010, 49, 4771-4.
21. Chim H, Sontich JK, Kaufman BR. Free tissue transfer with distraction osteogenesis is effective for limb salvage of the infected traumatized lower extremity. Plast Reconstr Surg 2011, 127, 2364-72.
22. Choi J, Kim K, Kim T, Liu G, Bar-Shir A, et al. Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds. J Control Release 2011, 156, 239-45.
23. Christopher R, Morrison DWG, Ni B, Rubin J, Yadav V, et al. Microscale hydrogels for medicine and biology: synthesis, characteristics, and applications. J Mech Mater Struc 2007, 2, 1102-19.
24. Cosentino C, Amato F, Walczak R, Boiarski A, Ferrari M. Dynamic model of biomolecular diffusion through two-dimensional nanochannels. J Phys Chem B 2005, 109, 7358-64.
25. Dai Q, Nelson A. Magnetically-responsive self assembled composites. Chem Soc Rev 2010, 39, 4057-66.
26. Daroczi B, Kari G, McAleer MF, Wolf JC, Rodeck U, Dicker AP. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafi sh model. Clin Cancer Res 2006, 12, 7086-91.
27. Debiotech SA Switzerland. Retrieved January 2012 from http:// www.debiotech.com.
28. Desai TA, Hansford DJ, Kulinsky L, Nashat AH, Rasi G, et al. Nanopore technology for biomedical applications. Biomed Microdevices 1999, 2, 11-40.
29. Dutta P, Beskok A, Warburton T. Electroosmotic fl ow control in complex microgeometries. J Microelectromech Syst 2002, 11, 36-44.
30. Evans CH, Palmer GD, Pascher A, Porter R, Kwong FN, et al. Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 2007, 13, 1987-93.
31. Farra R, Sheppard NF Jr., McCabe L, Neer RM, Anderson JM, et al. First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med 2012, 4, 122ra21.
32. Fine D, Grattoni A, Hosali S, Ziemys A, De Rosa E, et al. A robust nanofl uidic membrane with tunable zero-order release for implantable dose specifi c drug delivery. Lab Chip 2010, 10, 3074-83.
33. Fine D, Grattoni A, Zabre E, Hussein F, Ferrari M, Liu X. A lowvoltage electrokinetic nanochannel drug delivery system. Lab Chip 2011, 11, 2526-34.
34. Finnskog D, Ressine A, Laurell T, Marko-Varga G. Integrated protein microchip assay with dual fl uorescent and MALDI read-out. J Proteome Res 2004, 3, 988-94.
35. Fisher OZ, Khademhosseini A, Langer R, Peppas NA. Bioinspired materials for controlling stem cell fate. Acc Chem Res 2010, 43, 419-28.
36. Gordon MJ, Huang X, Pentoney SL, Zare RN. Capillary electrophoresis. Science 1988, 242, 224-8.
37. Grattoni A, Fine D, Zabre E, Ziemys A, Gill J, et al. Gated and near-surface diffusion of charged fullerenes in nanochannels. ACS Nano 2011, 5, 9382-91.
38. Grattoni A, Fine D, Ziemys A, Gill J, Zabre E, et al. Nanochannel systems for personalized therapy and laboratory diagnostics. Curr Pharm Biotechnol 2010, 11, 343-65.
39. Grattoni A, Parazynski S, Hussain F. NanoGlands: NanoFluidic implants for personalized medicine. ASME Mech Eng 2011, 133, 23-6.
40. Grattoni A, Shen H, Fine D, Ziemys A, Gill JS, et al. Nanochannel technology for metronomic delivery of chemotherapeutics. Pharm Res 2011, 28, 292-300.
41. Gruber K, Horlacher T, Castelli R, Mader A, Seeberger PH, Hermann BA. Cantilever array sensors detect specifi c carbohydrate-protein interactions with picomolar sensitivity. ACS Nano 2011, 5, 3670-8.
42. Guo X, Park H, Liu G, Liu W, Cao Y, et al. In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials 2009, 30, 2741-52.
43. Hu Y, Bouamrani A, Tasciotti E, Li L, Liu X, Ferrari M. Tailoring of the nanotexture of mesoporous silica fi lms and their functionalized derivatives for selectively harvesting low molecular weight protein. ACS Nano 2010, 4, 439-51.
44. Hu Y, Peng Y, Lin K, Shen H, Brousseau LC, 3rd et al. Surface engineering on mesoporous silica chips for enriching low molecular weight phosphorylated proteins. Nanoscale 2011, 3, 421-8.
45. James P. Protein identifi cation in the post-genome era: the rapid rise of proteomics. Q Rev Biophys 1997, 30, 279-331.
46. Rambaut PC, Johnson P. Prolonged weightlessness and calcium loss in man. Acta Astronaut 1979, 6, 1113-22.
47. Kakudo N, Kushida S, Minakata T, Suzuki K, Kusumoto K. Plateletrich plasma promotes epithelialization and angiogenesis in a splitthickness skin graft donor site. Med Mol Morphol 2011, 44, 233-6.
48. Karnik R, Fan R, Yue M, Li D, Yang P, Majumdar A. Electrostatic control of ions and molecules in nanofl uidic transistors. Nano Lett 2005, 5, 943-8.
49. Klöck G, Pfeffermann A, Ryser C, Gröhn P, Kuttler B, et al. Biocompatibility of mannuronic acid-rich alginates. Biomaterials 1997, 18, 707-13.
50. Kraehenbuehl TP, Ferreira LS, Zammaretti P, Hubbell JA, Langer R. Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials 2009, 30, 4318-24.
51. Langer R. New methods of drug delivery. Science 1990; 249: 1527-33.
52. Lanza RP, Langer RS, Vacanti J, eds. Principles of tissue engineering. Amsterdam: Elsevier Academic Press; 2007:1307.
53. Lee JE, Lee N, Kim T, Kim J, Hyeon T. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res 2011, 44, 893-902.
54. Li S, Shi Q, Liu G, Zhang W, Wang Z, et al. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions. J Appl Physiol 2010, 108, 1241-9.
55. Litster S, Suss ME, Santiago JG. A two-liquid electroosmotic pump using low applied voltage and power. Sens Actuators A Phys 2010, 163, 311-4.
56. Lutz AM, Willmann JK, Cochran FV, Ray P, Gambhir SS. Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes. PLoS Med 2008, 5, e170.
57. Martin F, Walczak R, Boiarski A, Cohen M, West T, et al. Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics. J Control Release 2005, 102, 123-33 .; corrected in J Control Release 2005;107:183.
58. Meneilly GS, Ryan AS, Veldhuis JD, Elahi D. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J Clin Endocrinol Metab 1997, 82, 4088-93.
59. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, et al. Engineering complex tissues. Tissue Eng 2006, 12, 3307-39.
60. Mistry AS, Pham QP, Schouten C, Yeh T, Christenson EM, et al. In vivo bone biocompatibility and degradation of porous fumarate-based polymer/alumoxane nanocomposites for bone tissue engineering. J Biomed Mater Res A 2010, 92, 451-62.
61. Mormont MC, Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer 2003, 97, 155-69.
62. Nabavi N, Khandani A, Camirand A, Harrison RE. Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion. Bone 2011, 49, 965-74.
63. Orive G, Anitua E, Pedraz JL, Emerich DF. Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci 2009, 10, 682-92.
64. Pan S, Aebersold R, Chen R, Rush J, Goodlett DR, et al. Mass spectrometry based targeted protein quantifi cation: methods and applications. J Proteome Res 2009, 8, 787-97.
65. Papadimitropoulos A, Mastrogiacomo M, Peyrin F, Molinari E, Komlev VS, et al. Kinetics of in vivo bone deposition by bone marrow stromal cells within a resorbable porous calcium phosphate scaffold: an X-ray computed microtomography study. Biotechnol Bioeng 2007, 98, 271-81.
66. Plecis A, Schoch R, Renaud P. Ionic transport phenomena in nanofl uidics: experimental and theoretical study of the exclusion enrichment effect on a chip. Nano Lett 2005, 5, 1147-55.
67. Prescott JH, Lipka S, Baldwin S, Sheppard NF, Jr., Maloney JM, et al. Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol 2006, 24, 437-8.
68. Ressine A, Ekstrom S, Marko-Varga G, Laurell T. Macro-/ nanoporous silicon as a support for high-performance protein microarrays. Anal Chem 2003, 75, 6968-74.
69. Ricciardi C, Canavese G, Castagna R, Ferrante I, Ricci A, et al. Integration of microfl uidic and cantilever technology for biosensing application in liquid environment. Biosens Bioelectron 2010, 26, 1565-70.
70. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. Towards a proteome-scale map of the human proteinprotein interaction network. Nature 2005, 437, 1173-8.
71. Sambu S, Xu X, Schiffer HA, Cui ZF, Ye H. RGDS-fuctionalized alginates improve the survival rate of encapsulated embryonic stem cells during cryopreservation. Cryo Letters 2011; 32: 389-401.
72. Sambu S, Xu X, Ye H, Cui ZF. Predicting the survival rate of mouse embryonic stem cells cryopreserved in alginate beads. Proc Inst Mech Eng H 2011, 225, 1092-107.
73. Samchenko Y, Ulberg Z, Korotych O. Multipurpose smart hydrogel systems. Adv Colloid Interface Sci 2011, 168, 247-62.
74. Santini JT, Cima MJ, Langer R. A controlled-release microchip. Nature 1999, 397, 335-8.
75. Schasfoort RBM, Schlautmann S, Hendrikse J, van den Berg A. Field-effect flow control for microfabricated fluidic networks. Science 1999, 286, 942-5.
76. Scheindlin S. Transdermal drug delivery: past, present, future. Mol Interv 2004, 4, 308-12.
77. Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer 2012, 12, 39-50.
78. Serda RE, Ferrati S, Godin B, Tasciotti E, Liu X, et al. Mitotic traffi cking of silicon microparticles. Nanoscale 2009, 1, 250-9.
79. Sharma S, Nijdam AJ, Sinha PM, Walczak RJ, Liu X, et al. Controlledrelease microchips. Expert Opin Drug Deliv 2006, 3, 379-94.
80. Song B, Wu C, Chang J. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profi les. Acta Biomater 2012, 8, 1901-7.
81. Sparreboom W, van den Berg A, Eijkel JCT. Principles and applications of nanofl uidic transport. Nat Nanotechnol 2009, 4, 713-20.
82. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122, 957-68.
83. Suárez-González D, Barnhart K, Saito E, Vanderby R, Jr., Hollister SJ, et al. Controlled nucleation of hydroxyapatite on alginate scaffolds for stem cell-based bone tissue engineering. J Biomed Mater Res A 2010, 95, 222-34.
84. Tamburro D, Fredolini C, Espina V, Douglas TA, Ranganathan A, et al. Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers. J Am Chem Soc 2011; 133: 19178-88.
85. Tampieri A, Landi E, Valentini F, Sandri M, D'Alessandro T, et al. A conceptually new type of bio-hybrid scaffold for bone regeneration. Nanotechnology 2011, 22, 015104.
86. Tanaka T, Mangala LS, Vivas-Mejia PE, Nieves-Alicea R, Mann AP, et al. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res 2010, 70, 3687-96.
87. Tasciotti E, Godin B, Martinez JO, Chiappini C, Bhavane R, et al. Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles. Mol Imaging 2011, 10, 56-68.
88. Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008; 3: 151-7.
89. Temenoff JS, Mikos AG. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 2000, 21, 2405-12.
90. Vaccari L, Canton D, Zaffaron N, Villa R, Tormen M, di Fabrizio E. Porous silicon as drug carrier for controlled delivery of doxorubicin anticancer agent. Microelectron Eng 2006, 83, 1598-601.
91. Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, et al. Correcting common errors in identifying cancer-specifi c serum peptide signatures. J Proteome Res 2005, 4, 1060-72.
92. Walczak R, Boiarski A, Cohen M, West T, Melnik K, et al. Longterm biocompatibility of NanoGATE drug delivery implant. NanoBiotechnology 2005, 1, 35-42.
93. Wu G, Datar RH, Hansen KM, Thundat T, Cote RJ, Majumdar A. Bioassay of prostate-specifi c antigen (PSA) using microcantilevers. Nat Biotechnol 2001, 19, 856-60.
94. Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 2004, 10, 955-64.
95. Yang J, Chen Q, Chen F, Zhang Q, Wang K, Fu Q. Realizing the full nanofiller enhancement in melt-spun fi bers of poly(vinylidene fl uoride)/carbon nanotube composites. Nanotechnology 2011, 22, 355707.
96. Yang SY, Yang JA, Kim ES, Jeon G, Oh EJ, et al. Single-file diffusion of protein drugs through cylindrical nanochannels. ACS Nano 2010, 4, 3817-22.
97. Zhou H, Xu HH. The fast release of stem cells from alginate-fi brin microbeads in injectable scaffolds for bone tissue engineering. Biomaterials 2011, 32, 7503-13.
98. Ziemys A, Kojic M, Milosevic M, Kojic N, Hussain F, et al. Hierarchical modeling of diffusive transport through nanochannels by coupling molecular dynamics with fi nite element method. J Comput Phys 2011, 230, 5722-31.